Clinical Trials Logo

Clinical Trial Summary

This is a prospective, observational multicenter study to collect blood from patients with mucopolysaccharidosis type IH undergoing laronidase therapy and a stem cell transplant. Sixteen patients will be enrolled over a 24 month period.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05634512
Study type Observational
Source Masonic Cancer Center, University of Minnesota
Contact Kim Nelson, RN
Phone 612-273-2925
Email knelso62@fiarview.org
Status Recruiting
Phase
Start date November 17, 2022
Completion date October 1, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03179761 - High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients Phase 2
Recruiting NCT05090345 - A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
Completed NCT05600101 - Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation N/A
Recruiting NCT05866302 - Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Completed NCT04139577 - FMT In High-Risk Acute GVHD After ALLO HCT Phase 1
Completed NCT04727827 - Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation N/A